Aviptadil
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Inhaled Aviptadil for the Treatment of COVID-19 in Patients at High Risk for ARDS (NCT04536350) | Prof. Dr. Jörg Leuppi | 2021-05-18 |
Track Aviptadil automatically
Every clearance here is in the API, with alerts when new ones post.